The peer-reviewed publication this week in Nature Publishing Cell Death & Disease(1) provides compelling support for the hypothesis that iron dysregulation is not merely a bystander, but a potential ...

PulseSight Therapeutics, a clinical stage ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology welcomes the publication of new ...

By tracing when variations in the human genome first appeared, researchers have found that advances in cognitive abilities ...

An artificial vision sensor inspired by the human pupil adapts automatically to light, maintaining clear perception from ...